These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 1320902)
21. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. Engelmann H; Novick D; Wallach D J Biol Chem; 1990 Jan; 265(3):1531-6. PubMed ID: 2153136 [TBL] [Abstract][Full Text] [Related]
22. Multimeric structure of the tumor necrosis factor receptor of HeLa cells. Smith RA; Baglioni C J Biol Chem; 1989 Sep; 264(25):14646-52. PubMed ID: 2549028 [TBL] [Abstract][Full Text] [Related]
23. Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity. Kull FC; Jacobs S; Cuatrecasas P Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5756-60. PubMed ID: 2994048 [TBL] [Abstract][Full Text] [Related]
24. Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor. Pennica D; Lam VT; Weber RF; Kohr WJ; Basa LJ; Spellman MW; Ashkenazi A; Shire SJ; Goeddel DV Biochemistry; 1993 Mar; 32(12):3131-8. PubMed ID: 8384489 [TBL] [Abstract][Full Text] [Related]
25. Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-alpha induced receptor aggregation. Pennica D; Kohr WJ; Fendly BM; Shire SJ; Raab HE; Borchardt PE; Lewis M; Goeddel DV Biochemistry; 1992 Feb; 31(4):1134-41. PubMed ID: 1310420 [TBL] [Abstract][Full Text] [Related]
26. Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor. Seckinger P; Zhang JH; Hauptmann B; Dayer JM Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5188-92. PubMed ID: 2164226 [TBL] [Abstract][Full Text] [Related]
27. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. Espevik T; Brockhaus M; Loetscher H; Nonstad U; Shalaby R J Exp Med; 1990 Feb; 171(2):415-26. PubMed ID: 1689365 [TBL] [Abstract][Full Text] [Related]
28. Biochemical properties of the 75-kDa tumor necrosis factor receptor. Characterization of ligand binding, internalization, and receptor phosphorylation. Pennica D; Lam VT; Mize NK; Weber RF; Lewis M; Fendly BM; Lipari MT; Goeddel DV J Biol Chem; 1992 Oct; 267(29):21172-8. PubMed ID: 1328224 [TBL] [Abstract][Full Text] [Related]
29. Characterization and affinity cross-linking of receptors for human recombinant lymphotoxin (tumor necrosis factor-beta) on a human histiocytic lymphoma cell line, U-937. Stauber GB; Aggarwal BB J Biol Chem; 1989 Feb; 264(6):3573-6. PubMed ID: 2536752 [TBL] [Abstract][Full Text] [Related]
30. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). Hohmann HP; Remy R; Brockhaus M; van Loon AP J Biol Chem; 1989 Sep; 264(25):14927-34. PubMed ID: 2549042 [TBL] [Abstract][Full Text] [Related]
31. Quantification and characterization of high-affinity membrane receptors for tumor necrosis factor on human leukemic cell lines. Scheurich P; Ucer U; Krönke M; Pfizenmaier K Int J Cancer; 1986 Jul; 38(1):127-33. PubMed ID: 3087891 [TBL] [Abstract][Full Text] [Related]
32. Modulation of two forms of tumor necrosis factor receptors and their cellular response by soluble receptors and their monoclonal antibodies. Higuchi M; Aggarwal BB J Biol Chem; 1992 Oct; 267(29):20892-9. PubMed ID: 1328214 [TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Gatanaga T; Hwang CD; Kohr W; Cappuccini F; Lucci JA; Jeffes EW; Lentz R; Tomich J; Yamamoto RS; Granger GA Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8781-4. PubMed ID: 2174164 [TBL] [Abstract][Full Text] [Related]
35. Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors. Smith RA; Kirstein M; Fiers W; Baglioni C J Biol Chem; 1986 Nov; 261(32):14871-4. PubMed ID: 3021754 [TBL] [Abstract][Full Text] [Related]
36. Binding of human TNF-alpha to high-affinity cell surface receptors: effect of IFN. Israel S; Hahn T; Holtmann H; Wallach D Immunol Lett; 1986 Apr; 12(4):217-24. PubMed ID: 2424831 [TBL] [Abstract][Full Text] [Related]
37. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Brockhaus M; Schoenfeld HJ; Schlaeger EJ; Hunziker W; Lesslauer W; Loetscher H Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3127-31. PubMed ID: 2158104 [TBL] [Abstract][Full Text] [Related]
38. Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor. Seckinger P; Isaaz S; Dayer JM J Biol Chem; 1989 Jul; 264(20):11966-73. PubMed ID: 2545692 [TBL] [Abstract][Full Text] [Related]
39. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. Engelmann H; Aderka D; Rubinstein M; Rotman D; Wallach D J Biol Chem; 1989 Jul; 264(20):11974-80. PubMed ID: 2545693 [TBL] [Abstract][Full Text] [Related]
40. The active form of tumor necrosis factor is a trimer. Smith RA; Baglioni C J Biol Chem; 1987 May; 262(15):6951-4. PubMed ID: 3034874 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]